4519:TYO
Chugai Pharmaceutical Co Ltd
¥6,843.00
arrow_upward
+0.31%(+21.00) 1D
Nov 2, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
¥6,852
High
¥6,922
Low
¥6,792
Mkt. cap
11.49T
Avg. vol.
3.47M
Volume
3.20M
Dividend
2.02%
Quarterly dividend
¥34
Ex-dividend date
Jun 29, 2026
P/E ratio
22.36
52-wk high
¥10,700
52-wk low
¥5,974
EPS
¥306
Shares outstanding
547.19M
No. of employees
5K
Open
¥6,852
High
¥6,922
Low
¥6,792
Mkt. cap
11.49T
Avg. vol.
3.47M
Volume
3.20M
Dividend
2.02%
Quarterly dividend
¥34
Ex-dividend date
Jun 29, 2026
P/E ratio
22.36
52-wk high
¥10,700
52-wk low
¥5,974
EPS
¥306
Shares outstanding
547.19M
No. of employees
5K
News stories
From web sources and news partners
TradingView
·
19 hours ago
Weekly Recap: Earnings growth and positive divarasib Phase III results
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp